Merck Gets Win In Patent Suit Over Diabetes Drugs
A West Virginia federal judge has found that Mylan Pharmaceuticals Inc.'s planned generics of a pair of multibillion-dollar-selling diabetes drugs sold by Merck & Co. Inc. would infringe Merck's patents on...To view the full article, register now.
Already a subscriber? Click here to view full article